Target
Granzyme B
Ligand
BDBM605120
Substrate
n/a
Meas. Tech.
Biochemical Assay
IC50
150±n/a nM
Citation
 Bilcer, GMKelly, TA Granzyme B directed imaging and therapy US Patent  US11667645 Publication Date 6/6/2023 
Target
Name:
Granzyme B
Synonyms:
CGL1 | CSPB | CTLA1 | GRAB_HUMAN | GRB | GZMB
Type:
PROTEIN
Mol. Mass.:
27735.56
Organism:
Homo sapiens (Human)
Description:
ChEMBL_469245
Residue:
247
Sequence:
MQPILLLLAFLLLPRADAGEIIGGHEAKPHSRPYMAYLMIWDQKSLKRCGGFLIRDDFVLTAAHCWGSSINVTLGAHNIKEQEPTQQFIPVKRPIPHPAYNPKNFSNDIMLLQLERKAKRTRAVQPLRLPSNKAQVKPGQTCSVAGWGQTAPLGKHSHTLQEVKMTVQEDRKCESDLRHYYDSTIELCVGDPEIKKTSFKGDSGGPLVCNKVAQGIVSYGRNNGMPPRACTKVSSFVHWIKKTMKRY
  
Inhibitor
Name:
BDBM605120
Synonyms:
(2S,5S)-5-[(S)-2-(2-Methoxy- benzoylamino)-3-methyl- butyrylamino]-4-oxo-1,2,4,5,6,7- hexahydro-azepino[3,2,1-hi]indole-2- carboxylic acid (1H-[1,2,3]triazol-4- ylmethyl)-amide | US11667645, Compound C063
Type:
Small organic molecule
Emp. Form.:
C29H33N7O5
Mol. Mass.:
559.6162
SMILES:
COc1ccccc1C(=O)N[C@@H](C(C)C)C(=O)N[C@H]1CCc2cccc3C[C@H](N(c23)C1=O)C(=O)NCc1c[nH]nn1 |r|
Structure:
Search PDB for entries with ligand similarity: